, Tracking Stock Market Picks
Enter Symbol:
Array Biopharma Inc. (ARRY) [hlAlert]

down 0.34 %

Array Biopharma Inc. (ARRY) rated Outperform by William Blair

Posted on: Thursday,  Feb 7, 2008  10:25 AM ET by William Blair

William Blair rated Outperform Array Biopharma Inc. (NASDAQ: ARRY) on 02/07/2008, when the stock price was $5.86. Since
then, Array Biopharma Inc. has lost 0.34% as of 01/15/2016's recent price of $5.84.
If you would have followed this William Blair's recommendation on ARRY, you would have lost 0.34% of your investment in 2899 days.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/7/2008 10:25 AM Buy
as of 12/24/2008
1 Week up  3.16 %
1 Month up  11.83 %
3 Months down  -17.46 %
1 YTD down  -27.65 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy